Considering the different roles played by Cx43 in GBM progression, it will be extremely important in the development of novel therapeutic strategies for GBM treatment (Xing et al. 2019 [111]) to selectively target Cx43 of specific cell types (tumoral or non tumoral), carefully considering the stage of glioma genesis. This evidence concerns the gene GJA1 and central nervous system cancer.